The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-phenyl-5H-pyridazino[4,3-b]indol-3-amine ID: ALA5183240
Max Phase: Preclinical
Molecular Formula: C16H12N4
Molecular Weight: 260.30
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nnc2c([nH]c3ccccc32)c1-c1ccccc1
Standard InChI: InChI=1S/C16H12N4/c17-16-13(10-6-2-1-3-7-10)15-14(19-20-16)11-8-4-5-9-12(11)18-15/h1-9,18H,(H2,17,20)
Standard InChI Key: DHDZFJQQXROKLC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
-1.9161 0.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3283 1.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9165 2.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0913 2.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6796 1.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0875 0.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1423 1.3552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2277 0.5548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5296 0.2187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7909 1.8275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5270 1.5015 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6137 0.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9667 0.2275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9667 -0.5975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6813 -1.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6805 -1.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9657 -2.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2538 -1.8366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2490 -1.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3283 0.2928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
5 7 1 0
7 8 2 0
9 8 1 0
6 9 1 0
7 10 1 0
11 10 2 0
12 11 1 0
13 12 2 0
8 13 1 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
14 19 1 0
19 18 2 0
12 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 260.30Molecular Weight (Monoisotopic): 260.1062AlogP: 3.36#Rotatable Bonds: 1Polar Surface Area: 67.59Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.14CX Basic pKa: 7.40CX LogP: 2.69CX LogD: 2.39Aromatic Rings: 4Heavy Atoms: 20QED Weighted: 0.55Np Likeness Score: -0.29
References 1. Taylor AM, Bailey C, Belmont LD, Campbell R, Cantone N, Côté A, Crawford TD, Cummings R, DeMent K, Duplessis M, Flynn M, Good AC, Huang HR, Joshi S, Leblanc Y, Murray J, Nasveschuk CG, Neiss A, Poy F, Romero FA, Sandy P, Tang Y, Tsui V, Zawadzke L, Sims RJ, Audia JE, Bellon SF, Magnuson SR, Albrecht BK, Cochran AG.. (2022) GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1., 65 (16.0): [PMID:35930799 ] [10.1021/acs.jmedchem.2c00662 ]